Drug Type Small molecule drug |
Synonyms LTK-14A |
Target |
Action inhibitors |
Mechanism EP300 inhibitors(Histone acetyltransferase p300 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Preclinical | India | 22 Sep 2022 |





